The skincare brand, launched in 2000 and known for its clinical-grade products, has received strategic growth investment from the private equity firm Main Post. Terms of the deal were not disclosed.
Join our network of executives who receive the MBS News daily, as well as the insights, analysis and our weekly column in The Weekend Edition.
You’ll be able to unsubscribe at any time.